A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention

被引：0
|
作者：
Sharma, SK
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 04期
关键词：
D O I：
10.1016/j.amjcard.2003.07.051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：524 / 525
页数：2
相关论文
共 50 条
  • [11] Delivery of Glycoprotein IIb/IIIa Inhibitor Therapy for Percutaneous Coronary Intervention Why Not Take the Intracoronary Highway?
    Gurbel, Paul A.
    Tantry, Udaya S.
    CIRCULATION, 2010, 121 (06) : 739 - 741
  • [12] Gender impact on in-hospital outcomes after percutaneous coronary intervention
    Cardoso, Cristiano Oliveira
    Cardoso, Carlos Roberto
    Rodrigues, La Hore Correa
    Staudt, Clacir
    Miller, Vasco Morosini
    Somavilla Duarte, Aldo Fernando
    Cabrera Yordi, Luis Maria
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (01) : 106 - 109
  • [13] The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent era
    Adelman, AG
    Caramori, PRA
    Cohen, EA
    Chisholm, RJ
    Cote, G
    Ducas, J
    O'Neill, BJ
    Tcheng, JE
    CANADIAN JOURNAL OF CARDIOLOGY, 1998, 14 (08) : 1057 - 1066
  • [14] Platelet glycoprotein IIb IIIa antagonists in percutaneous coronary revascularization
    Dangas, G
    Colombo, A
    AMERICAN HEART JOURNAL, 1999, 138 (01) : S16 - S23
  • [15] Vascular access site complications after percutaneous coronary intervention with glycoprotein IIb/IIIa receptor inhibitor therapy in the EPIC trial
    Blankenship, JC
    Hellkamp, AS
    Demko, SL
    Aguirre, FV
    Topol, EJ
    Califf, RM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 99310 - 99310
  • [16] Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes
    Harrington, RA
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2004, 30 (06): : 639 - 647
  • [17] Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention
    Gumina, Richard J.
    Yang, Eric H.
    Sandhu, Gurpreet S.
    Prasad, Abhiram
    Bresnahan, John F.
    Lennon, Ryan J.
    Rihal, Charanjit S.
    Holmes, David R., Jr.
    Singh, Mandeep
    MAYO CLINIC PROCEEDINGS, 2008, 83 (09) : 995 - 1001
  • [18] Impact of Chronic Thrombocytopenia on In-Hospital Outcomes After Percutaneous Coronary Intervention
    Ayoub, Karam
    Marji, Meera
    Ogunbayo, Gbolahan
    Masri, Ahmad
    Abdel-Latif, Ahmed
    Ziada, Khaled
    Vallurupalli, Srikanth
    JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (18) : 1862 - 1868
  • [19] Rescue' platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: Bailing out of a sunken ship
    Kandzari, DE
    Tcheng, JE
    Harrington, RA
    Sketch, MH
    JOURNAL OF INVASIVE CARDIOLOGY, 2000, 12 (10): : 502 - 504
  • [20] Monitoring platelet function in glycoprotein IIb/IIIa inhibitor therapy
    Wu, KK
    Willerson, JT
    CIRCULATION, 2001, 103 (21) : 2528 - 2530
12345